查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1834095

低温管瓶市场：按材料、容量、无菌性、封闭性、自动化相容性、最终用户和应用划分 - 全球预测 2025-2032

Cryogenic Vials Market by Material, Volume, Sterility, Closure, Automation Compatibility, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，低温管瓶市场将成长至 8.4298 亿美元，复合年增长率为 5.42%。

主要市场统计数据
基准年2024年 5.5233亿美元
预计2025年 5.8267亿美元
预测年份：2032年 8.4298亿美元
复合年增长率（%） 5.42%

简明解释为什么您选择的低温管瓶会影响实验室完整性、自动化相容性以及生命科学工作流程中的下游样品价值

低温管瓶的应用范围涵盖生物医学研究、诊断、生物样本库和治疗开发等关键工作流程。材料科学、封闭技术和自动化相容性的最新创新，正在将管瓶从一个简单的容器提升为实验室品质系统的重要组成部分。随着样本完整性标准日益严格，通量需求不断增长，实验室和生物样本库正在重新调整其供应商选择标准，优先考虑无菌保证、可追溯性以及与自动化平台的生命週期相容性。

本介绍解释了为什么低温管瓶的选择不仅仅关乎储存。材料性能、密封可靠性和自动化相容性的相互作用决定了样品的长期存活率和操作效率。从学术实验室到药物研发团队，相关人员需要能够无缝整合到其工作流程中的管瓶，同时满足无菌和污染控制方面的监管要求。因此，采购决策现在不仅取决于价格，还取决于对产品属性、供应商能力以及对下游营运影响的多方面评估。

展望未来，市场参与企业应该期望他们的采购和研发团队要求标准化规范，以减少整个供应链的变化并支援与自动化系统的互通性。本介绍为深入探讨产业转型、关税导致的供应链压力、细分细微差别、区域差异、竞争动态以及为寻求驾驭快速发展的生态系统的领导者提供实用建议奠定了基础。

材料、封闭工程和自动化相容性的进步如何融合，重新定义产品标准、供应商检验和采购期望

低温管瓶产业正在经历一场变革，其驱动力来自技术、监管和营运因素，这些因素正在重新定义产品要求和供应商期望。聚合物化学和玻璃配方的进步使其具有耐低温性能，并减少了可萃取物，从而增强了样品的长期储存能力，并使其更适用于敏感的检测。同时，从增强型O形圈材料到磁性和卡扣式瓶盖设计的瓶盖创新，正在降低洩漏风险，并促进日常物料输送中快速、可靠的取用。

同时，自动化浪潮正在改变采购重点。全自动和半自动化系统需要标准化的管瓶形状、坚固的封盖介面和一致的製造公差，以确保可靠的取放操作。这种转变强调了供应商能够检验相容性并提供机器人操作的测试数据。法规和品质要求也日益严格，要求供应商在标准商业性合约中提供灭菌验证、可追溯性记录和材料安全文件。

最后，供应链弹性和环境考量正在推动製造商优化物流，并探索可回收和低碳材料的选择。这些因素的汇聚正迫使现有企业和新参与企业都在产品差异化、认证途径以及与最终用户的共同检验方面进行投资，以在日益严峻的市场中保持竞争力。

了解美国关税措施的变化将如何影响低温管瓶相关人员的供应链策略、采购决策和业务连续性

源自美国的关税政策发展和贸易行动可能会对管瓶供应链中的零件采购、製造足迹和定价策略产生重大影响。当进口关税和相关贸易法规调整时，下游采购商通常面临更长的采购前置作业时间和更高的国际采购产品和原材料到岸成本。此类成本压力往往促使製造商重新评估筹资策略，例如近岸外包、回岸外包或多元化供应商基础，以降低风险并稳定供应连续性。

政策週期内关税变动的累积效应通常会波及到製造决策和库存策略。供应商可能会加速垂直整合，将关键流程外包，并减轻关税波动的影响，或者他们可能会重新协商合约条款，将成本转嫁给最终买家。在营运方面，由于供应商优先考虑在新的贸易条件下更具经济可行性的核心SKU，实验室和生物样本库的管理人员可能会面临间歇性的SKU合理化。同时，如果原料集中在受关税影响的地区，依赖特殊玻璃配方或特定聚合物等级的组织可能会面临采购摩擦。

为了因应这些动态，商业领袖应将关税情境规划纳入其采购和定价框架，儘早评估替代材料和供应商方案，并与值得信赖的供应商进行联合预测。即使贸易政策变化导致市场暂时中断，就成本结构和应急计画进行透明的对话也将有助于稳定供应链、维护产品品质并维持服务水准。

深度細項分析揭示了材料化学、体积格式、封闭机制和自动化相容性如何影响产品设计和采购选择

细分市场动态揭示了低温冻存管瓶领域产品设计和最终用户需求的差异。硼硅酸和钠石灰等玻璃具有不同的热稳定性和化学稳定性，而聚乙烯和聚丙烯等塑胶则具有更高的抗衝击性和可客製化的成型工艺，从而易于实现自动化生产。因此，材料决策——平衡热性能、与低温保存介质的兼容性以及物料输送的耐用性——会影响不同类型实验室的采购选择。

1.5毫升、2毫升、5毫升和10毫升等容量类别直接考虑了样本类型和通量。较小的容量支援微量滴定工作流程和高密度生物样本库，而较大的容量则适用于大量储存和运输。无菌产品分为非无菌产品和无菌产品，它们决定了市场对无菌验证和包装控制的期望，尤其是涉及临床或监管研究样本时。密封系统——磁力盖、O形圈、螺旋盖、卡扣盖——是容器完整性和快速取用之间的关键接口，每种密封类型都在防洩漏性、自动化兼容性和用户人体工学之间进行了权衡。

自动化适用性将产品分为全自动、半自动和手动类别，规定了设计公差、插入/移除可靠性以及条码和机架介面要求。涵盖学术和研究机构、生物库、生物技术公司、诊断实验室、医院和製药公司的最终用户细分阐明了预期性能如何根据应用环境、监管负担和吞吐量需求而变化。最后，专注于冷冻保存、样品储存和运输等应用的细分融合了功能要求。例如，运输管瓶优先考虑抗衝击性和安全封闭性，而冷冻保存管瓶强调热循环耐久性和最小可萃取物。这些细分层共同构成一个矩阵，为寻求满足客户需求的供应商提供产品蓝图、验证承诺和商业性定位的资讯。

美洲、欧洲、中东和非洲地区以及亚太地区的需求模式、管理体制和供应链基础设施将如何影响产品预期和打入市场策略

区域动态塑造了美洲、欧洲、中东和非洲以及亚太地区的需求驱动因素、监管预期和供应商生态系统，从而对低温管瓶相关人员产生了独特的营运和商业影响。美洲地区拥有大量研究实验室、生物製药开发和成熟的生物银行样本库，推动了对检验和记录的产品的需求以及高水准的服务期望。该地区高度重视供应商的回应能力、快速的前置作业时间以及适用于临床研发开发平臺的无菌认证产品线的可用性。

在欧洲、中东和非洲，监管协调工作和密集的临床实验室网路指南产品合规性和可追溯性实践。在该地区营运的供应商必须遵循错综复杂的国家法规，同时满足严格的品质系统要求，并且通常必须支援多语言文件和区域分销策略。在亚太地区，不断增加的研究投资、不断扩大的丛集以及不断提升的诊断能力，正在推动对经济高效的塑胶解决方案和高性能玻璃器皿的广泛需求。瞄准该地区的製造商通常强调扩充性的生产、本地伙伴关係和客製化，以支援多样化的最终用户群。

综合起来，这些区域模式表明，供应商可以从量身定制的市场进入方法中受益，该方法将全球产品标准与特定区域的支援、监管专业知识以及解决当地基础设施和采购行为的物流解决方案相结合。

竞争压力凸显了身为市场领导者，经过检验的自动化相容性、透明的品质系统和供应链弹性的重要性

低温管瓶领域的竞争态势取决于产品创新、生产规模以及检验与实验室自动化和法规要求相容性的能力。领先的供应商透过对先进材料、密封系统和灭菌验证的投资来脱颖而出，而其他供应商则在成本和针对大型机构客户的客製化能力方面展开竞争。管瓶製造商与自动化供应商或实验室整合商之间的策略伙伴关係，可以降低整合风险并加速其在高通量环境中的应用，从而强化价值命题。

供应方的竞争力也取决于品管体係以及透明的材料和製程文件。提供强大的可追溯性、批次级测试和第三方认证的公司通常能够确保其作为临床和製药终端用户的首选供应商的地位。製造地和供应链的韧性构成了另一个竞争力核心。拥有多元化生产基地和强大区域分销网络的公司更有能力应对关税衝击和物流中断。

最后，专注于永续性认证、可回收材料和新型封盖技术的新参与企业正在重塑买家的期望。现有供应商可能会透过扩展产品线和策略性併购来应对，从而缩短经过验证的自动化产品的上市时间。整体而言，竞争不仅需要强大的产品，还需要可验证的品质系统、验证支援以及与客户工作流程一致的营运可靠性。

製造商和采购商采取切实可行的策略行动，加强验证能力、多样化投入、增强可追溯性，以保护样品的完整性和供应的连续性。

产业领导者应采取可行的策略，使产品开发与不断发展的实验室工作流程、监管要求和供应链现实一致。首先，投资于跨职能验证项目，这些项目应在领先的自动化平台上展示可靠的效能，并为客户提供清晰、可重复的验收标准。此类验证可以降低整合风险，缩短引进週期，并在向高通量实验室和生物样本库销售产品时创造稳固的商业性优势。

其次，它增强了材料和瓶盖的多样化，并降低了特定投入品供应中断的风险。对替代玻璃配方和聚合物等级进行认证，并检验关键SKU的多种瓶盖类型，使製造商能够更灵活地应对关税变化、原材料短缺和需求激增。第三，它透过提供无菌证书、可萃取物/可浸出物资料和批次级可追溯性，增强了文件记录和可追溯性服务，满足了临床和製药客户的文件记录需求。清晰的文件记录有助于采购评估，并缩短受监管买家的资格确认时间。

第四，我们优先考虑区域製造和经销伙伴关係，以缩短前置作业时间并降低运费敏感度。最后，我们透过协作测试、客製化检验计划和教育计画积极与最终用户互动，以确保我们的产品设计能够应对实际操作中的挑战，并在整个生命週期中保持样品的完整性。

一种透明的、三管齐下的研究途径，结合主要相关人员访谈、技术文献综合和产品检验审查，得出可行的建议

本研究采用结构化方法，结合主要相关人员访谈、产品规格审查以及对监管指南和技术文献的案头综合，建构了坚实的分析基础。主要输入包括与实验室经理、采购主管、品质保证专业人员和产品工程师的对话，以了解疼痛管理的营运实务、验证要求和供应商选择标准。这些定性见解与製造商的技术文件、灭菌方案和材料科学出版物进行了交叉引用，以确认产品声称的性能与实验室实际需求之间的一致性。

二次分析纳入了官方监管指南、标准文件以及专家同行评审的关于低温保存、超低温材料稳定性和封盖性能的研究。在适当情况下，对设计属性进行了比较评估，以评估与材料相关的风险，包括自动化相容性、封盖完整性和可萃取物。调查方法强调来源归属的透明度、对专有声明的谨慎处理，以及基于情境的供应链和政策影响分析，以指导实际建议。

调查方法的限制包括供应商文件方法的多样性以及不断发展的自动化标准，这些都可能影响研究的普遍性。为了克服这些局限性，该方法优先考虑跨多个独立资讯来源的交叉检验，并尽可能纳入最终用户的测试回馈，以确保研究结果与实际操作相符。

总结为什么材料性能、检验的自动化相容性和弹性采购对于保护样品完整性和操作连续性至关重要

总而言之，低温管瓶领域正在从一种商品化的容器转变为性能关键型组件，影响样本的完整性、实验室通量和监管环境。材料创新和封盖工程正在满足更严格的低温保存和高灵敏度检测的需求，而自动化相容性正逐渐成为一项关键的商业性差异化因素，它能够减少物料输送的差异性并加速实验室工作流程。这些技术趋势与地缘政治和关税驱动的供应链动态同步发展，因此需要製定积极主动的筹资策略和应急计画。

对于研究、诊断、生物样本库和製药公司的相关人员来说，优先检验自动化相容性，坚持全面的文件记录和可追溯性，并聘请具备营运韧性和本地支援能力的供应商，才是未来的发展方向。投资于材料多样化、经验证的封盖和协作验证专案的製造商，将更有能力满足现代实验室日益严格的品质和吞吐量要求。

总的来说，这些发展凸显了需要采取一种策略性的、基于证据的方法来选择管瓶和设计供应链，以保留样品价值、最大限度地降低操作风险、并使产品功能适应不断发展的实验室工作流程。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 针对机器人处理进行最佳化的自动化相容低温管瓶快速增加
  • 推出可减少塑胶废弃物的环保低温管瓶材料
  • 支援数位 RFID 的低温管瓶在低温运输追踪中的应用日益广泛
  • 对高通量板式低温储存系统的需求推动了管瓶的创新
  • 开发先进的密封技术以防止样品污染
  • 加强实验室标准化低温管瓶检验通讯协定的监管
  • 用于保存光敏生物分子的抗紫外线低温管瓶的需求日益增长

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章 低温管瓶市场（依材料）

  • 玻璃
    • 硼硅酸
    • 钠石灰
  • 塑胶
    • 聚乙烯
    • 聚丙烯

9. 低温管瓶市场（按数量）

  • 1.5ml
  • 10ml
  • 2ml
  • 5ml

第 10 章低温管瓶市场：无菌性

  • 非无菌
  • 已灭菌

第 11 章 低温管瓶市场（依封闭）

  • 磁扣
  • O形圈
  • 螺旋盖
  • 按扣帽

第 12 章低温管瓶市场：自动化适用性

  • 全自动
  • 手动的
  • 半自动

第 13 章。低温管瓶市场（按最终用户）

  • 学术研究机构
  • 生物样本库
  • 生技公司
  • 诊断实验室
  • 医院
  • 製药公司

第14章 低温管瓶市场（依应用）

  • 冷冻保存
  • 样品储存
  • 运输

第 15 章。按地区分類的低温管瓶市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 低温管瓶市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 低温管瓶市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Corning Incorporated
    • Avantor, Inc.
    • Greiner Bio-One International GmbH
    • DWK Life Sciences GmbH
    • Eppendorf AG
    • Cole-Parmer Instrument Company, LLC
    • Labcon, Inc.
    • Simport Scientific Inc.
Product Code: MRR-4311CE1A33F4

The Cryogenic Vials Market is projected to grow by USD 842.98 million at a CAGR of 5.42% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 552.33 million
Estimated Year [2025] USD 582.67 million
Forecast Year [2032] USD 842.98 million
CAGR (%) 5.42%

A concise framing of why cryogenic vial selection now drives laboratory integrity, automation compatibility, and downstream sample value across life sciences workflows

The cryogenic vial landscape underpins critical workflows across biomedical research, diagnostics, biobanking, and therapeutic development. Recent innovations in material science, closure technologies, and automation compatibility have elevated the role of vials from mere containers to integral components of laboratory quality systems. As sample integrity standards tighten and throughput demands increase, laboratories and biorepositories are recalibrating vendor selection criteria to prioritize sterility assurance, traceability, and lifecycle compatibility with automated platforms.

This introduction frames why cryogenic vial selection matters beyond simple storage. The interplay of material performance, closure reliability, and automation-readiness governs long-term sample viability and operational efficiency. Stakeholders from academic research labs to pharmaceutical development teams require vials that integrate seamlessly into workflows while meeting regulatory expectations for sterility and contamination control. Consequently, procurement decisions now hinge on a multidimensional assessment of product attributes, supplier capabilities, and downstream operational impacts rather than price alone.

Looking forward, market participants should expect procurement and R&D teams to demand standardized specifications that reduce variability across supply chains and support interoperability with automated systems. This introduction sets the stage for a deeper exploration of transformative industry shifts, tariff-driven supply chain pressures, segmentation nuances, regional differences, competitive dynamics, and practical recommendations for leaders seeking to navigate a rapidly evolving ecosystem.

How advances in materials, closure engineering, and automation compatibility are converging to redefine product standards, supplier validation, and procurement expectations

The cryogenic vial sector is experiencing transformative shifts driven by technological, regulatory, and operational vectors that collectively redefine product requirements and supplier expectations. Advances in polymer chemistry and glass formulations are delivering improved low-temperature resilience and reduced leachables, enabling longer-term sample preservation and greater compatibility with high-sensitivity assays. At the same time, closure innovations-ranging from enhanced O-ring materials to magnetic and snap cap designs-are addressing leakage risk and facilitating rapid, reliable access during routine handling.

Concurrently, the automation wave is reshaping procurement priorities: fully automated and semi-automated systems demand standardized vial geometries, robust closure interfaces, and consistent manufacturing tolerances to ensure pick-and-place reliability. This shift places a premium on vendors that can validate compatibility and provide test data for robotic handling. Regulatory and quality expectations are also tightening; suppliers are being asked to present sterilization validation, traceability records, and material safety documentation as part of standard commercial engagement.

Finally, supply chain resilience and environmental considerations are pushing manufacturers to optimize logistics and explore recyclable or lower-carbon material choices. These converging forces are compelling incumbents and new entrants alike to invest in product differentiation, certification pathways, and collaborative validation with end users to remain competitive in an increasingly exacting market.

Understanding how shifts in United States tariff measures influence supply chain strategy, sourcing decisions, and operational continuity for cryogenic vial stakeholders

Tariff policy developments and trade measures emanating from the United States can exert outsized influence on component sourcing, manufacturing footprints, and pricing strategies within the cryogenic vial supply chain. When import duties or related trade restrictions are adjusted, downstream purchasers frequently encounter longer procurement lead times and higher landed costs for products or raw inputs sourced internationally. These cost pressures often encourage manufacturers to reassess sourcing strategies, which can include nearshoring, reshoring, or diversifying supplier bases to mitigate risk and stabilize supply continuity.

The cumulative effect of tariff changes in a given policy cycle typically reverberates through manufacturing decisions and inventory strategies. Suppliers may accelerate vertical integration to internalize critical processes and reduce exposure to duty fluctuations, or they may renegotiate contractual terms related to cost-pass-through to end buyers. Operationally, laboratory and biobank managers may face intermittent SKU rationalization as vendors prioritize core SKUs that are more economically viable under new trade conditions. In parallel, organizations that rely on specialized glass formulations or specific polymer grades could face procurement friction if those feedstocks are concentrated in jurisdictions affected by tariffs.

To navigate these dynamics, commercial leaders should incorporate tariff scenario planning into sourcing and pricing frameworks, evaluate alternate material or supplier options early, and engage in collaborative forecasting with trusted suppliers. Transparent dialogue about cost composition and contingency plans will help stabilize supply chains, preserve product quality, and maintain service levels even when trade policy shifts create transient market dislocations.

Deep segmentation analysis revealing how material chemistry, volume formats, closure mechanisms, and automation compatibility sculpt product design and procurement choices

Segment-level dynamics illuminate how product design and end-user requirements diverge across the cryogenic vial landscape. Material selection distinguishes glass and plastic pathways, where glass variants such as borosilicate and soda lime offer differing thermal and chemical stability profiles, and plastic options including polyethylene and polypropylene provide enhanced impact resistance and customizable molding for automation-friendly geometries. Decisions about material thus balance thermal performance, compatibility with cryopreservation media, and handling durability, influencing procurement choices across laboratory types.

Volume segmentation, spanning formats like 1.5ml, 2ml, 5ml, and 10ml, maps directly to sample type and throughput considerations; smaller volumes support microtiter workflows and high-density biobanking while larger formats address bulk storage and transport use cases. Sterility classification into non-sterile and sterile offerings shapes market expectations for sterilization validation and packaging controls, particularly where clinical or regulated research samples are involved. Closure systems-magnetic closure, O-ring, screw cap, and snap cap-represent a critical interface with containment integrity and rapid access, with each closure type offering trade-offs between leak resistance, automation compatibility, and user ergonomics.

Automation compatibility divides products into fully automated, semi-automated, and manual categories and drives design tolerances, insertion/retrieval reliability, and barcode or rack-interface requirements. End-user segmentation covering academic and research institutes, biobanks, biotechnology firms, diagnostic laboratories, hospitals, and pharmaceutical companies underscores how performance expectations vary by application context, regulatory burden, and throughput needs. Finally, application-focused distinctions such as cryopreservation, sample storage, and transport concentrate functional demands; for example, transport vials prioritize shock resistance and secure closures, whereas cryopreservation vials emphasize thermal cycling durability and minimal extractables. Together, these segmentation layers form a matrix that informs product roadmaps, validation commitments, and commercial positioning for suppliers seeking to align with customer requirements.

How regional demand patterns, regulatory regimes, and supply chain infrastructures across the Americas, EMEA, and Asia-Pacific determine product expectations and go-to-market strategies

Regional dynamics shape demand drivers, regulatory expectations, and supplier ecosystems across the Americas, Europe, Middle East & Africa, and Asia-Pacific, producing distinctive operational and commercial implications for cryogenic vial stakeholders. In the Americas, a concentration of research institutions, biopharmaceutical development, and established biobanking activity fuels demand for validated, heavily documented products and high service-level expectations. This region places a premium on supplier responsiveness, rapid lead times, and the availability of sterile, certified product lines suitable for clinical R&D pipelines.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and a dense network of clinical laboratories guide product compliance and traceability practices. Suppliers active in this region must navigate a mosaic of national regulations while meeting stringent quality system requirements, often supporting multilingual documentation and regional distribution strategies. In the Asia-Pacific region, rising research investment, expanding biotech clusters, and growing diagnostic capacity drive broad-based demand for both cost-effective plastic solutions and high-performance glass offerings. Manufacturers targeting this region frequently emphasize scalable production, local partnerships, and customization to support diverse end-user profiles.

Collectively, these regional patterns suggest that suppliers will benefit from tailored go-to-market approaches that combine global product standards with localized support, regulatory expertise, and logistics solutions that address regional infrastructure and procurement behaviors.

Competitive landscape pressures highlight the importance of validated automation compatibility, transparent quality systems, and supply chain resilience for market leadership

Competitive dynamics within the cryogenic vial sector are defined by product innovation, manufacturing scale, and the ability to validate compatibility with laboratory automation and regulatory requirements. Leading suppliers differentiate through investments in advanced materials, closure systems, and sterilization validation, while others compete on cost and customization capacity for large institutional clients. Strategic partnerships between vial manufacturers and automation vendors or laboratory integrators enhance the value proposition by reducing integration risk and accelerating adoption in high-throughput environments.

Supply-side competitiveness also rests on quality management systems and the transparency of material and process documentation. Firms that offer robust traceability, lot-level testing, and third-party certifications typically secure preferred supplier status among clinical and pharmaceutical end users. Manufacturing footprint and supply chain resilience constitute another axis of competitiveness; companies with diversified production locations or strong regional distribution networks are better positioned to absorb tariff shocks and logistics disruptions.

Finally, emerging entrants focusing on sustainability credentials, recyclable materials, or novel closure technologies are reshaping buyer expectations. Incumbent vendors may respond through incremental product enhancements or strategic M&A to expand portfolios and accelerate time-to-market for validated, automation-ready offerings. Overall, competitive success increasingly requires not just a strong product, but demonstrable quality systems, validation support, and operational reliability aligned with customer workflows.

Practical strategic actions for manufacturers and purchasers to strengthen validation capability, diversify inputs, and enhance traceability to safeguard sample integrity and supply continuity

Industry leaders should pursue actionable strategies that align product development with evolving laboratory workflows, regulatory expectations, and supply chain realities. First, invest in cross-functional validation programs that demonstrate reliable performance with leading automation platforms and provide customers with clear, reproducible acceptance criteria. Such validation reduces integration risk, shortens adoption cycles, and creates a defensible commercial advantage when selling into high-throughput laboratories and biobanks.

Second, strengthen material and closure diversification to mitigate exposure to input-specific supply disruptions. By qualifying alternate glass formulations and polymer grades, and by validating multiple closure types for key SKUs, manufacturers can respond more nimbly to tariff shifts, raw material scarcity, or sudden demand spikes. Third, enhance documentation and traceability offerings by providing sterilization certificates, extractables/leachables data, and lot-level traceability to meet the documentation needs of clinical and pharmaceutical customers. Clear documentation supports procurement evaluation and reduces time-to-qualification for regulated buyers.

Fourth, prioritize regional manufacturing and distribution partnerships to shorten lead times and lower freight sensitivity, while exploring sustainable material choices and packaging optimizations to respond to customer ESG goals. Finally, engage proactively with end users through collaborative pilots, custom validation projects, and educational programming to ensure product designs address real-world handling challenges and preserve sample integrity throughout the sample lifecycle.

A transparent and triangulated research approach combining primary stakeholder interviews, technical literature synthesis, and product validation reviews to ground practical recommendations

This research relied on a structured methodology combining primary stakeholder interviews, product specification reviews, and desk-based synthesis of regulatory guidance and technical literature to construct a robust analytical foundation. Primary inputs included dialogues with laboratory managers, procurement leads, quality assurance professionals, and product engineers to capture operational pain points, validation requirements, and vendor selection criteria. These qualitative insights were triangulated with technical documentation from manufacturers, sterilization protocols, and materials science publications to ensure alignment between claimed product performance and practical laboratory needs.

Secondary analysis incorporated public regulatory guidance, standards documents, and peer-reviewed research on cryopreservation, material stability at ultra-low temperatures, and closure performance. Where appropriate, comparative evaluation of design attributes was performed to assess automation compatibility, closure integrity, and material-related risks such as extractables. The methodological approach emphasized transparency in source attribution, careful treatment of proprietary claims, and scenario-based analysis for supply chain and policy impacts to guide practical recommendations.

Limitations of the methodology include variability in vendor documentation practices and the evolving nature of automation standards, which can affect generalizability. To mitigate these limitations, the approach prioritized cross-validation across multiple independent sources and incorporated end-user testing feedback where available to ground findings in operational reality.

Synthesis of why material performance, validated automation compatibility, and resilient sourcing are essential to protect sample integrity and operational continuity

In conclusion, the cryogenic vial landscape is transitioning from commoditized containers to performance-critical components that influence sample integrity, laboratory throughput, and regulatory compliance. Material innovations and closure engineering are meeting the demands of more rigorous cryopreservation and high-sensitivity assays, while automation compatibility is emerging as a key commercial differentiator that reduces handling variability and accelerates laboratory workflows. These technological trends are occurring alongside geopolitical and tariff-driven supply chain dynamics that require proactive sourcing strategies and contingency planning.

For stakeholders across research institutions, diagnostics, biobanking, and pharmaceutical organizations, the path forward includes prioritizing validated compatibility with automation, insisting on comprehensive documentation and traceability, and engaging suppliers that demonstrate operational resilience and regional support capabilities. Manufacturers that invest in material diversification, validated closures, and collaborative validation programs will be better positioned to meet the tightening quality and throughput expectations of modern laboratories.

Taken together, these developments underscore the need for a strategic, evidence-based approach to vial selection and supply chain design that preserves sample value, minimizes operational risk, and aligns product capabilities with evolving laboratory workflows.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Surge in automation-compatible cryogenic vials optimized for robotic handling
  • 5.2. Emergence of eco-friendly cryogenic vial materials reducing plastic waste
  • 5.3. Growing adoption of digital RFID-enabled cryogenic vials for cold chain tracking
  • 5.4. Demand for high-throughput plate-based cryogenic storage systems boosting vial innovation
  • 5.5. Development of advanced hermetic sealing technologies to prevent sample contamination
  • 5.6. Increased regulatory focus on standardized cryogenic vial validation protocols across labs
  • 5.7. Rising need for UV-resistant cryogenic vials in light-sensitive biomolecule preservation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cryogenic Vials Market, by Material

  • 8.1. Glass
    • 8.1.1. Borosilicate
    • 8.1.2. Soda Lime
  • 8.2. Plastic
    • 8.2.1. Polyethylene
    • 8.2.2. Polypropylene

9. Cryogenic Vials Market, by Volume

  • 9.1. 1.5ml
  • 9.2. 10ml
  • 9.3. 2ml
  • 9.4. 5ml

10. Cryogenic Vials Market, by Sterility

  • 10.1. Non Sterile
  • 10.2. Sterile

11. Cryogenic Vials Market, by Closure

  • 11.1. Magnetic Closure
  • 11.2. O Ring
  • 11.3. Screw Cap
  • 11.4. Snap Cap

12. Cryogenic Vials Market, by Automation Compatibility

  • 12.1. Fully Automated
  • 12.2. Manual
  • 12.3. Semi Automated

13. Cryogenic Vials Market, by End User

  • 13.1. Academic & Research Institutes
  • 13.2. Biobanks
  • 13.3. Biotechnology Firms
  • 13.4. Diagnostic Laboratories
  • 13.5. Hospitals
  • 13.6. Pharmaceutical Companies

14. Cryogenic Vials Market, by Application

  • 14.1. Cryopreservation
  • 14.2. Sample Storage
  • 14.3. Transport

15. Cryogenic Vials Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Cryogenic Vials Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Cryogenic Vials Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Thermo Fisher Scientific Inc.
    • 18.3.2. Merck KGaA
    • 18.3.3. Corning Incorporated
    • 18.3.4. Avantor, Inc.
    • 18.3.5. Greiner Bio-One International GmbH
    • 18.3.6. DWK Life Sciences GmbH
    • 18.3.7. Eppendorf AG
    • 18.3.8. Cole-Parmer Instrument Company, LLC
    • 18.3.9. Labcon, Inc.
    • 18.3.10. Simport Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. CRYOGENIC VIALS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. CRYOGENIC VIALS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CRYOGENIC VIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BOROSILICATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SODA LIME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 1.5ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 10ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 2ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY 5ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MAGNETIC CLOSURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY O RING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SNAP CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOBANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY SAMPLE STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 317. AFRICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 318. AFRICA CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 319. AFRICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 320. AFRICA CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 323. AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 324. AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 325. AFRICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 326. AFRICA CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 327. AFRICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 328. AFRICA CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 329. AFRICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 330. AFRICA CRYOGENIC VIALS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 331. AFRICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. AFRICA CRYOGENIC VIALS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 336. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 337. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 338. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 339. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 340. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 341. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
  • TABLE 342. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
  • TABLE 343. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 344. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 345. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2018-2024 (USD MILLION)
  • TABLE 346. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY CLOSURE, 2025-2032 (USD MILLION)
  • TABLE 347. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2018-2024 (USD MILLION)
  • TABLE 348. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY AUTOMATION COMPATIBILITY, 2025-2032 (USD MILLION)
  • TABLE 349. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 350. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE,